Use of antithrombotic agents during pregnancy

被引：90

作者：

Ginsberg, JS ^{[1
]}

Hirsh, J ^{[1
]}

机构：

[1] McMaster Univ, Med Ctr, Hamilton, ON L8N 3Z5, Canada

来源：

CHEST | 1998年 / 114卷 / 05期

关键词：

D O I：

10.1378/chest.114.5_Supplement.524S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：524S / 530S

页数：7

共 57 条

[1]

ANDERSON DR, 1991, THROMB HAEMOSTASIS, V65, P248

[2] THE USE OF AN INDWELLING TEFLON CATHETER FOR SUBCUTANEOUS HEPARIN ADMINISTRATION DURING PREGNANCY - A RANDOMIZED CROSSOVER STUDY [J].

ANDERSON, DR ;

GINSBERG, JS ;

BRILLEDWARDS, P ;

DEMERS, C ;

BURROWS, RF ;

HIRSH, J .

ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (07) :841-844

[3]

[Anonymous], REPORT CONFIDENTIAL

[4]

BADARACCO MA, 1974, BRIT MED J, V1, P214

[5] A PROSPECTIVE-STUDY OF HEPARIN-INDUCED OSTEOPOROSIS IN PREGNANCY USING BONE DENSITOMETRY [J].

BARBOUR, LA ;

KICK, SD ;

STEINER, JF ;

LOVERDE, ME ;

HEDDLESTON, LN ;

LEAR, JL ;

BARON, AE ;

BARTON, PL .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (03) :862-869

[6] CHONDRODYSPLASIA PUNCTATA - IS MATERNAL WARFARIN THERAPY A FACTOR [J].

BECKER, MH ;

GENIESER, NB ;

FINEGOLD, M ;

MIRANDA, D ;

SPACKMAN, T .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1975, 129 (03) :356-359

[7]

BEROYZ G, 1994, LANCET, V343, P619

[8]

BONNAR J, 1981, CLIN OBSTET GYNAECOL, V8, P455

[9] ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY [J].

BRILLEDWARDS, P ;

GINSBERG, JS ;

JOHNSTON, M ;

HIRSH, J .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :104-109

[10]

CONARD J, 1990, THROMB HAEMOSTASIS, V63, P319

← 1 2 3 4 5 6 →